1. 2022
  2. The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol

    Terpstra, L. C., Altenburg, J., Bronsveld, I., Doodeman, H. J., Rozemeijer, W., Heijerman, H. G. M. & Boersma, W. G., 1 Dec 2022, In: Contemporary Clinical Trials Communications. 30, 101045.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Composition and diversity analysis of the lung microbiome in patients with suspected ventilator-associated pneumonia

    BreathDx Consortium, Dec 2022, In: Critical care (London, England). 26, 1, p. 203 1 p., 203.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study

    the RECoVERED Study Group, Verveen, A., Wynberg, E., van Willigen, H. D. G., Davidovich, U., Lok, A., Moll van Charante, E. P., de Jong, M. D., de Bree, G., Prins, M., Knoop, H., Nieuwkerk, P. T., Agard, I., Ayal, J., Cavdar, F., Craanen, M., Deuring, A., van Dijk, A., Ersan, E., del Grande, L., & 36 othersHartman, J., Koedoot, N., Leenstra, T., Lebbink, R., Loomans, D., Makowska, A., du Maine, T., de Man, I., Matser, A., van der Meij, L., van Polanen, M., Oud, M., Reid, C., Storey, L., van Wijk, M., van den Aardweg, J., van Assem, J., van Beek, M., Blankert, T., Dijkstra, M., Figaroa, O., Frenkel, L., van Gils, M., van Haga, J., Han, X. A., Harskamp-Holwerda, A., Hazenberg, M., Hidad, S., de Jong, N., Kootstra, N., Kuijt, L., Russell, C., van der Straten, K., van der Veen, A., Verkaik, B. & Visser, G. R., Dec 2022, In: BMC medicine. 20, 1, 422.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper

    Neumann, E., Schreeck, F., Herberg, J., Jacqz Aigrain, E., Maitland-van der Zee, A. H., Pérez-Martínez, A., Hawcutt, D. B., Schaeffeler, E., Rane, A., de Wildt, S. N. & Schwab, M., Dec 2022, In: British journal of clinical pharmacology. 88, 12, p. 5017-5033 17 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  6. Migration and allergic diseases: Findings from a population-based study in adults in Amsterdam, the Netherlands

    Amoah, A. S., Prins, M., Bel, E. H. D., Fokkens, W. J., Zwinderman, A. H., Yazdanbakhsh, M., Maitland-van der Zee, A. H. & van Ree, R., Dec 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 12, p. 3667-3670 4 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  7. Evaluation of the Factors Associated with Prescribed and Non-Prescribed Medicine: A Population-Based Study

    Eskandari, M., Alizadeh Bahmani, A. H., Hoorang, M., Zare, M., Afifi, S., Karimzadeh, I., Azadi, S., Sabzghabaee, A. M., Lankarani, K. B., Ahmadizar, F. & Peymani, P., 3 Nov 2022, (E-pub ahead of print) In: Current drug safety.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Analysis of Exosomal MicroRNA Dynamics in Response to Rhinovirus Challenge in a Longitudinal Case-Control Study of Asthma

    Wang, W., Sinha, A., Lutter, R., Yang, J., Ascoli, C., Sterk, P. J., Nemsick, N. K., Perkins, D. L. & Finn, P. W., 1 Nov 2022, In: Viruses. 14, 11, 2444.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Bronchoscopic Journey of in vivo Real-Time Microscopic Imaging in ILD: A Case Series

    Wijmans, L., Kalverda, K., de Bruin, D., Brinkman, P., van den Berk, I., Roelofs, J. J. T. H., Jonkers, R., Bonta, P. I. & Annema, J., 1 Nov 2022, In: Respiration; international review of thoracic diseases. 101, 11, p. 1006-1014 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Crossover Patient Outcomes for Targeted Lung Denervation in Moderate to Severe Chronic Obstructive Pulmonary Disease: AIRFLOW-2

    AIRFLOW-2 Trial Study Group, 1 Nov 2022, In: Respiration; international review of thoracic diseases. 101, 11, p. 1069-1074 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 19375